Senolytic Agent Delivery refers to the targeted administration of compounds, known as senolytics, that selectively induce programmed cell death (apoptosis) in senescent cells. Senescent cells are damaged cells that accumulate with age and secrete pro-inflammatory factors, contributing to tissue dysfunction and chronic disease. Effective delivery aims to maximize the agent’s concentration at sites of senescent cell burden while minimizing systemic toxicity. This clearance process is a key strategy in longevity science.
Origin
The term combines “senolytic,” derived from senex (old) and lysis (to destroy), with “agent delivery,” the pharmacological process of getting the therapeutic compound to its target. This concept is central to the field of longevity medicine, which seeks to clear these detrimental cells to improve tissue function and healthspan. Senescent cells are a major contributor to the “inflammaging” process, which profoundly impacts hormonal regulation.
Mechanism
The mechanism involves the senolytic agent disrupting the pro-survival pathways that senescent cells employ to resist apoptosis. Once these pathways are inhibited, the senescent cell undergoes programmed cell death and is subsequently cleared by the immune system. Targeted delivery, often through specific formulations or carrier molecules, is critical to ensure the senolytic action is precise and does not affect healthy, non-senescent cells.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.